CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Oventus Medical Ltd (in Liquidation) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Oventus Medical Ltd (in Liquidation)
1 Swann Road, Indooroopilly,
PO Box 190
Phone: +61 300533159p:+61 300533159 BRISBANE, QLD  4068  Australia
On 1/19/2023, a Resolution to Voluntarily Wind Up Oventus Medical Ltd under S49 of the Corporations Act was approved. Michael Gerard McCann and Graham Robert Killer of Grant Thornton Australia Limited were appointed as the Liquidators of the Company.
This company is no longer actively traded on any major stock exchange.
Business Summary
Oventus Medical Limited is an Australia-based medical device company. The Company is commercializing a treatment platform for obstructive sleep apnea (OSA) and snoring. The Company’s O2Vent devices are designed for any patient that is deemed appropriate for oral appliance therapy, but especially beneficial for the many people that suffer with nasal congestion, obstruction and mouth breathing. The Company’s product offerings include Oventus O2Vent Optima, O2Vent Optima, the ExVent and O2Vent Optima Mini. The Oventus O2Vent Optima product range provides relief to people who suffer snoring or mild to moderate OSA, and those who are unable to tolerate continuous positive airway pressure (CPAP) therapy. Its O2Vent Optima is an oral appliance, which features an integrated airway, using its own airway technology to treat the upper airway. It provides an uninterrupted airflow during sleep, as well as when a patient experiences nasal obstruction.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20216/30/2021Yes----

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Chief Scientific Officer JohnCox 1/30/2022 1/30/2022
Chief Financial Officer DanielParry 12/5/2017 12/5/2017
Senior Vice President - Sales, Marketing and Operations, North America RobinRandolph
5 additional Officers and Directors records available in full report.

Business Names
Business Name
Oventus CRM Pty Ltd
Oventus Manufacturing Pty Ltd

General Information
Outstanding Shares: 241,726,535 (As of 12/31/2021)
Stock Exchange: ASX


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, October 30, 2024